• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

裂解型纤溶酶原激活物抑制剂-1(PAI-1)刺突的高质量结构

High quality structure of cleaved PAI-1-stab.

作者信息

Dewilde M, Strelkov S V, Rabijns A, Declerck P J

机构信息

Katholieke Universiteit Leuven, Belgium.

出版信息

J Struct Biol. 2009 Feb;165(2):126-32. doi: 10.1016/j.jsb.2008.11.001. Epub 2008 Nov 27.

DOI:10.1016/j.jsb.2008.11.001
PMID:19059484
Abstract

Here we report the crystal structure of a stablilized plasminogen activator inhibitor-1 variant (PAI-1-N150H-K154T-Q301P-Q319L-M354I (PAI-1-stab)) that shows a cleavage within the reactive centre loop. The new structure is of superior quality compared to the previously determined structure of the cleaved PAI-1-A335P mutant. We present a detailed comparison of the two structures and also compare them with the structure of the active PAI-1-stab. The structural data give important insights into the working mechanism of PAI-1 and also explain the role of various stabilizing mutations.

摘要

在此,我们报道了一种稳定化的纤溶酶原激活物抑制剂-1变体(PAI-1-N150H-K154T-Q301P-Q319L-M354I,即PAI-1-stab)的晶体结构,该变体在反应中心环内发生了裂解。与先前测定的裂解型PAI-1-A335P突变体结构相比,新结构质量更优。我们对这两种结构进行了详细比较,并将它们与活性PAI-1-stab的结构进行了对比。这些结构数据为PAI-1的作用机制提供了重要见解,也解释了各种稳定化突变的作用。

相似文献

1
High quality structure of cleaved PAI-1-stab.裂解型纤溶酶原激活物抑制剂-1(PAI-1)刺突的高质量结构
J Struct Biol. 2009 Feb;165(2):126-32. doi: 10.1016/j.jsb.2008.11.001. Epub 2008 Nov 27.
2
Comparative analysis of the proteinase specificity in wild-type and stabilized plasminogen activator inhibitor-1: evidence for contribution of intramolecular flexibility.野生型和稳定型纤溶酶原激活物抑制剂-1中蛋白酶特异性的比较分析:分子内柔韧性作用的证据
Biochem Biophys Res Commun. 2004 Aug 27;321(3):746-51. doi: 10.1016/j.bbrc.2004.07.023.
3
Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation.纤溶酶原激活物抑制剂1。天然丝氨酸蛋白酶抑制剂的结构,与其他构象的比较及其对丝氨酸蛋白酶抑制剂失活的影响。
J Mol Biol. 2000 Mar 31;297(3):683-95. doi: 10.1006/jmbi.2000.3604.
4
High-resolution structure of the stable plasminogen activator inhibitor type-1 variant 14-1B in its proteinase-cleaved form: a new tool for detailed interaction studies and modeling.稳定的1型纤溶酶原激活物抑制剂变体14-1B蛋白酶切割形式的高分辨率结构:用于详细相互作用研究和建模的新工具。
Protein Sci. 2008 Oct;17(10):1844-9. doi: 10.1110/ps.036707.108. Epub 2008 Aug 25.
5
Effect of stabilizing versus destabilizing interactions on plasminogen activator inhibitor-1.
Thromb Haemost. 2000 Nov;84(5):871-5.
6
The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion.纤溶酶原激活物抑制剂1的活性构象,一种控制纤维蛋白溶解和细胞黏附的药物靶点。
Structure. 1999 Feb 15;7(2):111-8. doi: 10.1016/S0969-2126(99)80018-5.
7
Characterization of a small molecule PAI-1 inhibitor, ZK4044.小分子纤溶酶原激活物抑制剂-1(PAI-1)抑制剂ZK4044的特性分析
Thromb Res. 2005;115(4):341-50. doi: 10.1016/j.thromres.2004.09.021. Epub 2004 Nov 13.
8
Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution--implications for serpin mechanistic model and prediction of nsSNP activities.纤溶酶原激活物抑制剂-2对P8残基取代具有高度耐受性——对丝氨酸蛋白酶抑制剂机制模型及单核苷酸多态性(nsSNP)活性预测的启示
J Mol Biol. 2005 Nov 11;353(5):1069-80. doi: 10.1016/j.jmb.2005.09.008. Epub 2005 Sep 22.
9
Crystallization and X-ray diffraction data of the cleaved form of plasminogen activator inhibitor-1.纤溶酶原激活物抑制剂-1裂解形式的结晶及X射线衍射数据
Proteins. 1995 Sep;23(1):118-21. doi: 10.1002/prot.340230114.
10
A model of the reactive form of plasminogen activator inhibitor-1.纤溶酶原激活物抑制剂-1反应形式的模型。
J Struct Biol. 1994 Nov-Dec;113(3):239-45. doi: 10.1006/jsbi.1994.1058.

引用本文的文献

1
Deep mutational scanning and massively parallel kinetics of plasminogen activator inhibitor-1 functional stability to probe its latency transition.深突变扫描和纤溶酶原激活物抑制剂-1 功能稳定性的大规模并行动力学,以探索其潜伏态转变。
J Biol Chem. 2022 Dec;298(12):102608. doi: 10.1016/j.jbc.2022.102608. Epub 2022 Oct 17.
2
A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?纤溶酶原激活物抑制剂-1 的综述及其(病理)生理学作用:靶向还是不靶向?
Int J Mol Sci. 2021 Mar 8;22(5):2721. doi: 10.3390/ijms22052721.
3
Structural Insight into the Two-Step Mechanism of PAI-1 Inhibition by Small Molecule TM5484.
小分子 TM5484 抑制 PAI-1 的两步机制的结构洞察。
Int J Mol Sci. 2021 Feb 2;22(3):1482. doi: 10.3390/ijms22031482.
4
Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition.心血管疾病中靶向纤溶酶原激活物抑制剂-1:纤溶酶原激活物抑制剂-1功能及抑制作用的结构见解
Front Cardiovasc Med. 2020 Dec 22;7:622473. doi: 10.3389/fcvm.2020.622473. eCollection 2020.
5
Molecular mechanism of two nanobodies that inhibit PAI-1 activity reveals a modulation at distinct stages of the PAI-1/plasminogen activator interaction.两种抑制纤溶酶原激活物抑制剂-1(PAI-1)活性的纳米抗体的分子机制揭示了PAI-1/纤溶酶原激活剂相互作用不同阶段的调节作用。
J Thromb Haemost. 2020 Mar;18(3):681-692. doi: 10.1111/jth.14716. Epub 2020 Feb 20.
6
Characterization of the Annonaceous acetogenin, annonacinone, a natural product inhibitor of plasminogen activator inhibitor-1.番荔枝乙酰精宁annonacinone的特性研究,一种纤溶酶原激活物抑制剂-1的天然产物抑制剂
Sci Rep. 2016 Nov 23;6:36462. doi: 10.1038/srep36462.
7
Functional stability of plasminogen activator inhibitor-1.纤溶酶原激活物抑制剂-1的功能稳定性
ScientificWorldJournal. 2014;2014:858293. doi: 10.1155/2014/858293. Epub 2014 Oct 15.
8
Structural basis for recognition of urokinase-type plasminogen activator by plasminogen activator inhibitor-1.尿激酶型纤溶酶原激活物与其抑制剂-1 识别的结构基础。
J Biol Chem. 2011 Mar 4;286(9):7027-32. doi: 10.1074/jbc.M110.204537. Epub 2011 Jan 3.